Transplanted grafts of pancreatic islet cells engineered to express Fas ligand are destroyed not protected by the immune system (pages 738–743).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bellgrau, D. et al. A role for CD95 ligand in preventing graft rejection. Nature 377, 630–632 (1995)
Griffith, T.S., Brunner, T., Fletcher, S.M., Green, D.R. & Ferguson, T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189–1192 (1995).
Nagata, S. & Suda, T. Fas and Fas ligand: lpr and gld mutations. Immunol. Today 16, 39–43 (1995)
Lau, H.T., Yu, M., Fontana, A. & Stoeckert, C.J. Prevention of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science 273, 109–112 (1996)
Korbutt, G. S., Elliott, J. F. & Rajotte, R.V. Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes 46, 317–322 (1997).
Kang, S-M. et al. Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction. Nature Med. 3, 738–743 (1997).
Chervonsky, A.V. et al. The role of Fas in autoimmune diabetes. Cell 89, 17–24 (1997)
Allison, J., Georgiou, H.M., Strasser, A. & Vaux, D.L. Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allograft. Proc. Nat. Acad. Sci. USA 94, 3943–3947 (1997).
Swenson, K. et al. Fas ligand gene transfer prolongs renal allograft survival in rats. Presented at 23rd annual meeting of the American Society of Transplant Surgeons. Chicago, Illinois, May 14th, 1997.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lau, H., Stoeckert, C. FasL — Too much of a good thing?. Nat Med 3, 727–728 (1997). https://doi.org/10.1038/nm0797-727
Issue Date:
DOI: https://doi.org/10.1038/nm0797-727